Soleno Therapeutics (SLNO) Debt Ratio (2013 - 2026)
Soleno Therapeutics (SLNO) reported Debt Ratio of 0.08 for Q1 2026, down 47.68% year-over-year from 0.16 in Q1 2025, and down 7.31% quarter-over-quarter from 0.09 in Q4 2025.
Soleno Therapeutics (SLNO) Debt Ratio (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 6 years of Debt Ratio data on file, last reported at 0.08 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.08, down 47.68% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.08 (down 47.68% YoY), and the FY2025 annual result was 0.09, down 41.26% from the prior year.
- Debt Ratio retreated to 0.08 in Q1 2026 per SLNO's latest filing, from 0.09 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.16 in Q1 2025 and troughed at 0.08 in Q1 2026.
- A 3-year average of 0.12 and a median of 0.12 in 2025 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2025 and 2026: Debt Ratio plunged 41.26% in 2025, then sank 47.68% in 2026.
- A 3-year view of Debt Ratio shows it stood at 0.15 in 2024, then sank by 41.26% to 0.09 in 2025, then dropped by 7.31% to 0.08 in 2026.
- Business Quant data shows SLNO's Debt Ratio at 0.08 in Q1 2026, 0.09 in Q4 2025, and 0.08 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.15 |
| Dec 31, 2015 | 0.11 |
| Sep 30, 2015 | 0.53 |
| Jun 30, 2015 | 1.26 |
| Dec 31, 2014 | 0.01 |
| Dec 31, 2013 | 8.82 |